Long-term observations of a patient with choroidal melanoma following fractionated stereotactic radiotherapy: a case report.
A 60-year-old man with choroidal melanoma was treated with fractionated stereotactic radiotherapy and followed for 6 years. During this period, the tumor has not changed in size, and the patient has experienced only a slight decrease in visual acuity. In this case, stereotactic radiotherapy appears to have been safe and effective and may also be a cost-effective alternative to particle or plaque therapy.
Tokuuye
K
K
Radiation Oncology Division, The National Cancer Center Hospital, Tokyo, Japan.
Sumi
M
M
Kagami
Y
Y
Murayama
S
S
Ikeda
H
H
Kaneko
A
A
Akine
Y
Y
D002830:Choroid Neoplasms / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery*; D019583:Dose Fractionation, Radiation; D005500:Follow-Up Studies; D005654:Fundus Oculi; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008545:Melanoma / Q000000981:diagnostic imaging / Q000473:pathology / Q000601:surgery*; D008875:Middle Aged; D016634:Radiosurgery / Q000379:methods*; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014792:Visual Acuity